Harding Loevner’s Allergan plc AGN Stock Holding History

Harding Loevner’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-720	Closed	-$121K	–	155
2018 Q1	$121K	Buy	+720	New	+$121K	﹤0.01%	82

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Harding Loevner's AGN Position: Q2 2018 in Review

Harding Loevner sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 720 shares — an estimated $121K sold.

Harding Loevner first reported a position in AGN in Q1 2018 and held it in 1 quarter. The position peaked at $121K in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

Harding Loevner reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
Harding Loevner sold 720 Allergan plc shares in Q2 2018, an estimated $121K.
Harding Loevner first reported a position in Allergan plc in Q1 2018 and held it in 1 quarter.
Harding Loevner's Allergan plc position peaked at $121K in Q1 2018.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Harding Loevner's 13F filing for Q2 2018, filed 14 Aug 2018.